Clinical Trials Directory

Trials / Sponsors / Titan Pharmaceuticals

Titan Pharmaceuticals

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
TerminatedRelative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Rop
Parkinson Disease
Phase 1 / Phase 22017-10-10
CompletedA Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine®
Opioid Dependence
Phase 32014-07-01
CompletedRe-Treatment Study of Probuphine in Opioid Addiction
Opioid Dependency
Phase 32010-11-01
CompletedA Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction
Opioid Dependency
Phase 32010-04-01
TerminatedA Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Depen
Opioid Dependence
Phase 32008-09-01
TerminatedStudy of Probuphine in Patients With Opioid Dependence
Opioid Dependency
Phase 32008-09-01
CompletedExtension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
Opioid Dependence
Phase 32007-10-01
CompletedSafety and Efficacy of Probuphine in the Treatment of Opioid Dependence
Opioid Dependence
Phase 32006-10-01
TerminatedStudy of DITPA in Patients With Congestive Heart Failure
Heart Failure, Congestive
Phase 22004-12-01
TerminatedA Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia
Leukemia, Lymphocytic, Chronic, Lymphoma, Small Lymphocytic
Phase 22004-05-01
TerminatedA Pilot Study of Pivanex in Patients With Malignant Melanoma
Malignant Melanoma
Phase 1 / Phase 22004-01-01
CompletedComparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell L
Carcinoma, Non-Small-Cell Lung
Phase 22003-09-01
TerminatedSafety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
Prostatic Neoplasms, Multiple Myeloma, Bladder Neoplasms
Phase 1 / Phase 22001-06-01